Skip to content

Issues: OpenSourceMycetoma/What-other-molecules-to-screen

New issue

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

Sign up for GitHub

By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.

Already on GitHub? Sign in to your account

11 Open 1 Closed
11 Open 1 Closed
Author
Filter by author
Loading
Label
Filter by label
Loading
Use alt + click/return to exclude labels
or ⇧ + click/return for logical OR
Projects
Filter by project
Loading
Milestones
Filter by milestone
Loading
Assignee
Filter by who’s assigned
Sort
Sort by
Newest Oldest Most commented Least commented Recently updated Least recently updated Best match
Most reactions
👍 👎 😄 🎉 😕 ❤️ 🚀 👀

Issues list

Interesting update on tafenoquine
#12 opened Jul 10, 2024 by MFernflower
3
Siderophores
#10 opened May 1, 2023 by wwjvdsande
7
Extracts from Kenya
#9 opened Mar 9, 2022 by Kjmondo
30
Merck Open Global Health Library Compounds Exist commerical sale or recent paper Reach out needed Someone needs to reach out to another team
#8 opened Mar 7, 2022 by mattodd
@wwjvdsande
2
Kinome Possible biological target Promising target to explore Question Further information is requested
#7 opened Nov 27, 2021 by mattodd
@mattodd
37
Proteomic data
#6 opened Jan 19, 2021 by wwjvdsande
@wwjvdsande
1
Paclobutrazol and friends
#5 opened Nov 29, 2019 by MFernflower
Oxazolidin-2-one-linked 1,2,3-triazole derivatives Reach out needed Someone needs to reach out to another team
#4 opened Oct 11, 2019 by MFernflower
@mattodd
Pandemic box data analysis Important
#3 opened Oct 7, 2019 by dmitrij176
16
Resorcylate Aminopyrazole Hsp90 Inhibitors Compounds Exist commerical sale or recent paper Reach out needed Someone needs to reach out to another team
#2 opened Oct 1, 2019 by mattodd
9
What other molecules to screen Question Further information is requested
#1 opened Sep 30, 2019 by wwjvdsande
30
ProTip! Follow long discussions with comments:>50.